$21.90
0.67% today
Nasdaq, Aug 12, 09:17 pm CET
ISIN
US74340E1038
Symbol
PGNY

Progyny Inc Stock price

$21.75
-1.46 6.29% 1M
-0.64 2.86% 6M
+4.50 26.09% YTD
+0.73 3.47% 1Y
-22.57 50.93% 3Y
-8.11 27.16% 5Y
+5.81 36.45% 10Y
+5.81 36.45% 20Y
Nasdaq, Closing price Mon, Aug 11 2025
-1.10 4.81%

Key metrics

Basic
Market capitalization
$1.9b
Enterprise Value
$1.6b
Net debt
positive
Cash
$256.1m
Shares outstanding
85.7m
Valuation (TTM | estimate)
P/E
37.5 | 39.0
P/S
1.5 | 1.5
EV/Sales
1.3 | 1.3
EV/FCF
8.2
P/B
4.0
Financial Health
Equity Ratio
69.5%
Return on Equity
12.9%
ROCE
14.8%
ROIC
-
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$1.2b | $1.3b
EBITDA
$76.7m | $204.4m
EBIT
$73.1m | $177.9m
Net Income
$52.5m | $47.8m
Free Cash Flow
$195.8m
Growth (TTM | estimate)
Revenue
9.5% | 7.6%
EBITDA
12.4% | 189.3%
EBIT
11.2% | 163.7%
Net Income
-14.3% | -12.0%
Free Cash Flow
2.9%
Margin (TTM | estimate)
Gross
22.0%
EBITDA
6.3% | 16.3%
EBIT
6.0%
Net
4.3% | 3.8%
Free Cash Flow
16.1%
More
EPS
$0.6
FCF per Share
$2.3
Short interest
12.7%
Employees
678
Rev per Employee
$1.7m
Show more

Is Progyny Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,027 stocks worldwide.

Progyny Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

16 Analysts have issued a Progyny Inc forecast:

10x Buy
63%
6x Hold
38%

Analyst Opinions

16 Analysts have issued a Progyny Inc forecast:

Buy
63%
Hold
38%

Financial data from Progyny Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
1,213 1,213
9% 9%
100%
- Direct Costs 946 946
9% 9%
78%
267 267
10% 10%
22%
- Selling and Administrative Expenses 194 194
9% 9%
16%
- Research and Development Expense - -
-
-
77 77
12% 12%
6%
- Depreciation and Amortization 3.57 3.57
43% 43%
0%
EBIT (Operating Income) EBIT 73 73
11% 11%
6%
Net Profit 53 53
14% 14%
4%

In millions USD.

Don't miss a Thing! We will send you all news about Progyny Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Progyny Inc Stock News

Neutral
Seeking Alpha
5 days ago
Progyny, Inc. (NASDAQ:PGNY ) Q2 2025 Earnings Conference Call August 7, 2025 4:45 PM ET Company Participants James Hart - Vice President of Investor Relations Mark S. Livingston - Chief Financial Officer Michael Sturmer - President Peter Anevski - CEO & Director Conference Call Participants Brian Gil Tanquilut - Jefferies LLC, Research Division Daniel Christopher Clark - Leerink Partners LLC, R...
Neutral
GlobeNewsWire
5 days ago
Reports Record Revenue of $332.9 Million, Reflecting 9.5% GrowthGenerates $55.5 Million in Quarterly Operating Cash Flow and Record $105.3 Million over the First Half of 2025 Raises Full Year Guidance to Reflect Continued Increase in Pacing of Member Engagement
Neutral
GlobeNewsWire
13 days ago
Increased awareness of expanded women's health and family building solutions has led to a growing disconnect between most wanted employee benefits and employer offerings Increased awareness of expanded women's health and family building solutions has led to a growing disconnect between most wanted employee benefits and employer offerings
More Progyny Inc News

Company Profile

Progyny, Inc. is a medical device company. It engages in the field of reproductive medicine, translating scientific discoveries related to early embryo development into clinical tools. The firm operates through the following segments: medical device and fertility benefits solution. The company's services include egg freezing, IVF treatment, surrogacy, podcast, adoption, and Eeva Test. The company was founded on April 03, 2008 and is headquartered in New York, NY.

Head office United States
CEO Peter Anevski
Employees 678
Founded 2008
Website www.progyny.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today